专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明申请

WO2004092209A9 S. PNEUMONIAE ANTIGENS 审中-公开
公开(公告)号：WO2004092209A9
公开(公告)日：2008-11-27
申请号：PCT/EP2004003984
申请日：2004-04-15
申请人： INTERCELL AG , MEINKE ANDREAS , NAGY ESZTER , HANNER MARKUS , DEWASTHALY SHAILESH , STIERSCHNEIDER ULRIKE
发明人： MEINKE ANDREAS , NAGY ESZTER , HANNER MARKUS , DEWASTHALY SHAILESH , STIERSCHNEIDER ULRIKE
IPC分类号： A61K39/00 , A61P31/04 , C07K14/315
CPC分类号： C07K14/3156 , A61K39/00 , A61K39/092 , C12Q1/689 , C12Q2600/158
摘要： The present invention discloses isolated nucleic acid molecules encoding a hyperimmune serum reactive antigen or a fragment thereof as well as hyperimmune serum reactive antigens or fragments thereof from S. pneumoniae, methods for isolating such antigens and specific uses thereof.
摘要翻译：本发明公开了编码超免疫血清反应性抗原或其片段的分离的核酸分子以及来自肺炎链球菌的超免疫血清反应性抗原或其片段，分离这些抗原的方法及其具体用途。

2. 发明申请

WO2009030676A3 PHARMACEUTICAL COMPOSITION COMPRISING A JAPANESE ENCEPHALITIS VIRUS FOR VACCINATION OF PATIENTS OF AT LEAST 40 YEARS OF AGE 审中-公开
公开(公告)号：WO2009030676A3
公开(公告)日：2009-03-12
申请号：PCT/EP2008/061527
申请日：2008-09-02
申请人： INTERCELL AG , TAUBER, Erich , DEWASTHALY, Shailesh , KLADE, Christoph , KALTENBÖCK, Astrid , SCHULLER, Elisabeth
发明人： TAUBER, Erich , DEWASTHALY, Shailesh , KLADE, Christoph , KALTENBÖCK, Astrid , SCHULLER, Elisabeth
IPC分类号： A61K39/12 , C12N7/04
摘要： The present invention relates to a pharmaceutical composition comprising a cell culture derived, inactivated JEV for use in the treatment or prevention of an infection with JEV in a human subject with at least 40 years of age.

3. 发明申请

WO2004092209A3 S. PNEUMONIAE ANTIGENS 审中-公开
标题翻译： S.PONUMONIAE抗原
公开(公告)号：WO2004092209A3
公开(公告)日：2004-12-09
申请号：PCT/EP2004003984
申请日：2004-04-15
申请人： INTERCELL AG , MEINKE ANDREAS , NAGY ESZTER , HANNER MARKUS , DEWASTHALY SHAILESH , STIERSCHNEIDER ULRIKE
发明人： MEINKE ANDREAS , NAGY ESZTER , HANNER MARKUS , DEWASTHALY SHAILESH , STIERSCHNEIDER ULRIKE
IPC分类号： A61K39/00 , A61P31/04 , C07K14/315 , A61K39/09 , C07K16/12 , C07K16/46 , C07K19/00 , C12N5/12 , C12N15/02 , C12Q1/68 , G01N33/569
CPC分类号： C07K14/3156 , A61K39/00 , A61K39/092 , C12Q1/689 , C12Q2600/158
摘要： The present invention discloses isolated nucleic acid molecules encoding a hyperimmune serum reactive antigen or a fragment thereof as well as hyperimmune serum reactive antigens or fragments thereof from S. pneumoniae, methods for isolating such antigens and specific uses thereof.
摘要翻译：本发明公开了编码超免疫血清反应性抗原或其片段的分离的核酸分子以及来自肺炎链球菌的超免疫血清反应性抗原或其片段，分离此类抗原的方法及其特定用途。

4. 发明申请

WO2009030676A2 PHARMACEUTICAL COMPOSITION COMPRISING A JAPANESE ENCEPHALITIS VIRUS FOR ADMINISTRATION TO A SPECIFIC PATIENT POPULATION 审中-公开
标题翻译：包含日本食品病毒的药物组合物用于特定患者人口的管理
公开(公告)号：WO2009030676A2
公开(公告)日：2009-03-12
申请号：PCT/EP2008061527
申请日：2008-09-02
申请人： INTERCELL AG , TAUBER ERICH , DEWASTHALY SHAILESH , KLADE CHRISTOPH , KALTENBOECK ASTRID , SCHULLER ELISABETH
发明人： TAUBER ERICH , DEWASTHALY SHAILESH , KLADE CHRISTOPH , KALTENBOECK ASTRID , SCHULLER ELISABETH
IPC分类号： A61K39/12 , A61P31/14
CPC分类号： A61K39/12 , A61K2039/5252 , A61K2039/55 , A61K2039/55505 , C12N2770/24134
摘要： The present invention relates to a pharmaceutical composition comprising a cell culture derived, inactivated JEV for use in the treatment or prevention of an infection with JEV in a human subject with at least 40 years of age. Furthermore, the invention relates to the use of a cell culture derived, inactivated JEV for the preparation of a pharmaceutical composition for the treatment or prevention of an infection with JEV, wherein the pharmaceutical composition is administered to a human subject with at least 40 years of age. The present invention also relates to a method for treating or preventing an infection with JEV, comprising the step of administering a therapeutically effective amount of a pharmaceutical composition comprising a cell culture derived, inactivated JEV to a human subject with at least 40 years of age. In another aspect, the invention relates to a pharmaceutical composition comprising a JEV for use in the treatment or prevention of an infection with JEV in a subject which has previously been vaccinated with a TBEV vaccine. In still another aspect, the invention relates to the use of a JEV for the preparation of a pharmaceutical composition for the treatment or prevention of an infection with JEV, wherein the pharmaceutical preparation is administered to a subject which has previously been vaccinated with a TBEV vaccine. The invention further relates to a method for treating or preventing an infection with JEV, comprising the steps of administering a therapeutically effective amount of a TBEV vaccine to a subject, and subsequently administering a therapeutically effective amount of a pharmaceutical composition comprising a JEV to said subject.
摘要翻译：本发明涉及一种药物组合物，其包含用于治疗或预防至少40岁的人受试者中JEV感染的细胞培养物衍生的灭活JEV。此外，本发明涉及用于制备用于治疗或预防JEV感染的药物组合物的细胞培养物衍生的灭活JEV的用途，其中所述药物组合物施用于至少40年的人类受试者年龄。本发明还涉及用于治疗或预防JEV感染的方法，包括向至少40岁的人受试者施用治疗有效量的包含细胞培养物衍生的灭活的JEV的药物组合物的步骤。另一方面，本发明涉及一种药物组合物，其包含用于治疗或预防以前用TBEV疫苗接种的受试者中的JEV感染的JEV。另一方面，本发明涉及JEV用于制备用于治疗或预防JEV感染的药物组合物的用途，其中所述药物制剂施用于先前已接种过TBEV疫苗的受试者。本发明还涉及用于治疗或预防JEV感染的方法，包括以下步骤：向受试者施用治疗有效量的TBEV疫苗，然后向所述受试者施用治疗有效量的包含JEV的药物组合物。

5. 发明申请

WO2004092209A2 S. PNEUMONIAE ANTIGENS 审中-公开
公开(公告)号：WO2004092209A2
公开(公告)日：2004-10-28
申请号：PCT/EP2004/003984
申请日：2004-04-15
申请人： INTERCELL AG , MEINKE, Andreas , NAGY, Eszter , HANNER, Markus , DEWASTHALY, Shailesh , STIERSCHNEIDER, Ulrike
发明人： MEINKE, Andreas , NAGY, Eszter , HANNER, Markus , DEWASTHALY, Shailesh , STIERSCHNEIDER, Ulrike
IPC分类号： C07K14/315
CPC分类号： C07K14/3156 , A61K39/00 , A61K39/092 , C12Q1/689 , C12Q2600/158
摘要： The present invention discloses isolated nucleic acid molecules encoding a hyperimmune serum reactive antigen or a fragment thereof as well as hyperimmune serum reactive antigens or fragments thereof from S. pneumoniae , methods for isolating such antigens and specific uses thereof.
摘要翻译：本发明公开了编码超免疫血清反应性抗原或其片段的分离的核酸分子以及来自肺炎链球菌的超免疫血清反应性抗原或其片段，分离该抗原的方法及其具体用途。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式